ALB and Hyperbilirubinemia: Clinical drugs with the ability to displace bilirubin from albumin-binding sites, subsequently leading to increased TSB, have been associated with certain causes of hyperbilirubinemia in neonates, especially in those with certain diseases or genetic variations [6,11].